AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

AbbVie has recently attracted investor attention with shares returning +4.3% over the past month, outperforming the S&P 500's +2.1% gain. However, despite strong earnings growth expectations (+104.3% YoY for current quarter) and consistent beats on both EPS and revenue estimates, the company received a Zacks Rank #4 (Sell) rating due to recent downward revisions in consensus earnings estimates. The stock is valued at par with peers (C grade) but may underperform the broader market in the near term.